Published in Chest on February 01, 2000
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Asthma exacerbations . 4: Prevention. Thorax (2006) 1.17
A randomised trial of self-management planning for adult patients admitted to hospital with acute asthma. Thorax (2002) 1.04
A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroid. Ther Clin Risk Manag (2007) 0.99
Action plans in asthma. Can Respir J (2006) 0.94
Respiratory medicine. Br J Gen Pract (2004) 0.92
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res (2006) 0.89
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract (2007) 0.84
New approaches to managing asthma: a US perspective. Ther Clin Risk Manag (2008) 0.81
The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J (2016) 0.77
Long-term management of asthma in First Nations and Inuit children: A knowledge translation tool based on Canadian paediatric asthma guidelines, intended for use by front-line health care professionals working in isolated communities. Paediatr Child Health (2012) 0.76
Supported self-management for asthma. Breathe (Sheff) (2015) 0.75
Asthma exacerbations: prevention is better than cure. Ther Clin Risk Manag (2005) 0.75
Asthma. BMJ (2007) 0.75
Short-term budesonide dosage. Chest (2001) 0.75
The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology (1995) 1.88
Th1/Th2 lymphocyte polarization in asthma. Allergy (2000) 1.21
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant (2010) 1.18
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant (2011) 1.18
Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood (1996) 1.01
Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med (1994) 0.92
Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant (1999) 0.87
Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation (1999) 0.87
Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathol Appl Neurobiol (2003) 0.85
Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. Respiration (1987) 0.84
Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study. Respiration (1986) 0.84
Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis (1971) 0.83
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. Aliment Pharmacol Ther (2008) 0.81
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc (2010) 0.81
Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients. Aliment Pharmacol Ther (2014) 0.81
Effects of "systemic" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Allergy (1995) 0.81
Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci (1994) 0.80
Eosinophil apoptosis in induced sputum from patients with seasonal allergic rhinitis and with asymptomatic and symptomatic asthma. Ann Allergy Asthma Immunol (2000) 0.79
Budesonide down-regulates eosinophil locomotion but has no effects on ECP release or on H2O2 production. Lung (1999) 0.78
Non-specific bronchial hyperresponsiveness induced by occupational exposure to different irritants. Clin Exp Allergy (1989) 0.78
Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients. Clin Exp Allergy (1998) 0.78
Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis. Arzneimittelforschung (1994) 0.77
Severe and relapsing upper gastrointestinal bleeding in a patient with Glanzmann's thrombasthenia. Dig Dis Sci (2000) 0.77
Extended transsphenoidal microsurgical approach for diaphragma sellae and tuberculum meningiomas. Minim Invasive Neurosurg (2010) 0.76
Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections. Chemioterapia (1986) 0.75
Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide. Clin Exp Allergy (1996) 0.75
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. Dig Liver Dis (2014) 0.75
[Bronchial dysreactive syndromes: bamifylline]. Arch Monaldi Mal Torace (1994) 0.75
[Experimental studies of the antimycobacterial activity of Rifampicine]. Arch Tisiol Mal Appar Respir (1966) 0.75
Respiratory and cardiovascular effects by inhalation of PGF 2alpha and PGE1 in laboratory animals. Agressologie (1976) 0.75
[The cure of tuberculosis in patients with primary infections at ther first verification]. Arch Tisiol Mal Appar Respir (1967) 0.75
[States of hyperdistention of the lung. II. Morphological characterization]. Arch Monaldi (1975) 0.75
Levodropropizine in the premedication to fibrebronchoscopy. Drugs Exp Clin Res (1991) 0.75
[On the pathogenesis of non-tuberculous suppurations of the pleura]. Arch Tisiol Mal Appar Respir (1969) 0.75
[Diagnosis and therapy of tuberculosis, today]. G Clin Med (1989) 0.75
[The use of nimesulide in respiratory disease]. Arch Monaldi Mal Torace (1994) 0.75
[Correlations between polygraphic and hemodynamic parameter changes induced by high concentrated oxygen administration in patients with mitral valvulopathy (author's transl)]. G Ital Cardiol (1980) 0.75
[On nosological classification of bronchial carcinoid]. Arch Monaldi (1971) 0.75
[States of hyperdistention of the lung. III. Antomo-functional correlations]. Arch Monaldi (1975) 0.75
[Elements of characterization in the clinical development of primary pulmonary cancer]. Arch Monaldi (1975) 0.75
Activity of rifampicin in experimental tuberculosis of the guinea pig. Chemotherapy (1967) 0.75
[Effectiveness of and tolerance to ceftibuten in the treatment of chronic bacterial bronchitis exacerbations in an elderly population]. Minerva Med (1996) 0.75
Impella recover 100 microaxial left ventricular assist device: the Niguarda experience. Transplant Proc (2004) 0.75
Pseudotumoral appearance of a duodenal diverticulum by ultrasonography: a case report. J Ultrasound Med (1993) 0.75
[Morphological and morphometric study of the distal bronchi in emphysema]. Bronchopneumologie (1980) 0.75
[Efficacy and tolerability of imipenem/cilastatin in infections at various sites]. G Ital Chemioter (1988) 0.75
[Therapeutic activity of the Rifampicin in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir (1967) 0.75
Beware of TIPS in liver transplant candidates. Transjugular Intrahepatic Portosystemic Shunt. Hepatogastroenterology (1997) 0.75
[A study tour of Prof. Monaldi in the East]. Arch Tisiol Mal Appar Respir (1967) 0.75
[Historical details on the pathologic anatomy of the tubercular cavern of the lung]. Arch Tisiol Mal Appar Respir (1968) 0.75
[Disabling respiratory diseases: sociomedical and organizational problems]. Arch Monaldi Mal Torace (1989) 0.75
[Anatomo-clinical characteristics of malignant connective tissue tumors of the lung]. Arch Monaldi (1981) 0.75
[Multiple hamartofibromas of the lung (anatomical and clinical contribution)]. Arch Tisiol Mal Appar Respir (1967) 0.75
[The role of rifampicin in the treatment of recent tubercular processes]. Arch Tisiol Mal Appar Respir (1968) 0.75
[Current treatment of chronic bronchopneumopathies]. Clin Ter (1974) 0.75
[Clinico-developmental peculiarities of bronchopulmonary infections in immunodepressed subjects]. Arch Monaldi (1984) 0.75
[Lung hyperdistension states. Nosological classification]. Arch Monaldi (1975) 0.75
[Diagnostic usefulness of cerebral single photon emission computed tomography (SPECT). Comparison with axial computed tomography]. Minerva Med (1988) 0.75
[Morphological and functional elements in the description of chronic obstructive bronchiolopathies]. Bronches (1976) 0.75
[Anatomo-functional correlations in chronic obstructive bronchopneumopathies]. Arch Monaldi (1976) 0.75
Pefloxacin in lower respiratory tract infections. J Antimicrob Chemother (1990) 0.75
Azelastine in the prophylactic treatment of bronchial asthma: an Italian multicentre comparison with ketotifen. J Int Med Res (1989) 0.75
Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Ann Allergy Asthma Immunol (1995) 0.75
[Morphological changes of the bronchi in some chronic bronchopneumopathies]. Arch Tisiol Mal Appar Respir (1966) 0.75
[Pathogenesis of non tuberculous pleural effusions]. Arch Tisiol Mal Appar Respir (1969) 0.75
[Possibilities of regression, with conservative treatment, of tuberculous adenobronchial syndromes]. Arch Monaldi (1971) 0.75
[Serum levels of GPI, AAT and CEA in primary lung neoplasms and chronic bronchopneumopathies]. Boll Ist Sieroter Milan (1979) 0.75
Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase. Eur J Clin Pharmacol (1994) 0.75
Our new journal. Why? Monaldi Arch Chest Dis (1993) 0.75
[Local treatment with bis-phenyl-(2-chlorophenyl)-1-imidazolil-methane of superficial mycoses of the pleural cavity overlying tuberculous or nontuberculous chronic suppuration]. G Ital Chemioter (1977) 0.75
[Why this meeting?]. Arch Monaldi Mal Torace (1992) 0.75
[Azelastine: evaluation of the protective effects in induced bronchospasm challenges]. Arch Monaldi Mal Torace (1989) 0.75
[Experimental bases of vaccination with BCG]. Arch Tisiol Mal Appar Respir (1968) 0.75
HBV-related cutaneous periarteritis nodosa in a patient 16 years after renal transplantation: efficacy of lamivudine. J Nephrol (2001) 0.75
[Treatment of infective recurrences of chronic bronchopneumopathies with Klebsiella pneumoniae extracts]. Arch Monaldi Mal Torace (1994) 0.75
[Natural course of chronic bronchitis as a disease determined by environmental risk factors]. Arch Monaldi Mal Torace (1994) 0.75
[Bronchial hamarto-chondroma]. Arch Tisiol Mal Appar Respir (1967) 0.75
[On the epidemiology of pulmonary mycoses due to Aspergillus]. Lotta Tuberc (1967) 0.75
Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma. Hepatogastroenterology (1989) 0.75
Fiberbronchoscopy and functional lung exploration. Panminerva Med (1987) 0.75
[Anatomic and early functional changes in the tracheo-bronchial tree after inhalation of various exogenous substances. Experimental studies]. Bronchopneumologie (1977) 0.75
[Parameters of ventilatory function in chronic bronchitis]. Bronchopneumologie (1982) 0.75
[Spontaneous pneumothorax from a medical viewpoint]. Arch Monaldi (1982) 0.75
[Pleural effusions]. Arch Monaldi (1985) 0.75
[On tubercular disease cycles ending with terminal miliary tuberculosis]. Riv Anat Patol Oncol (1966) 0.75
[States of hyperdistention of the lung. IV. Brief review. Characteristic elements]. Arch Monaldi (1975) 0.75
[Respiratory infections in immunodepressed patients based on personal experience]. Arch Monaldi (1984) 0.75
[On an unusual case of diffuse chondrodysplasia of the bronchial walls]. Arch Tisiol Mal Appar Respir (1968) 0.75
[Activity of terizidone in experimental tuberculosis in rabbits]. Arch Tisiol Mal Appar Respir (1969) 0.75
A study on the effects of some drugs on DOCA induced hypertension in the rat. Experientia (1980) 0.75
[Cefotetan in the therapy of respiratory infections. Multicenter research]. Clin Ter (1989) 0.75
[Pulmonary tuberculosis in advanced age. Causes of death and anatomopathologic pictures]. Riv Anat Patol Oncol (1966) 0.75
[CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results]. Arch Monaldi (1984) 0.75
[Pulmonary tuberculosis in contaminated environments]. Arch Monaldi Mal Torace (1994) 0.75
[Neoplastic metastases to the lung. Anatomopathological findings]. Arch Tisiol Mal Appar Respir (1966) 0.75
[Data on the morphological aspects and on the evolutive behavior of primary cancer of the lung with a single nodule]. Arch Tisiol Mal Appar Respir (1965) 0.75
[The hyper-transparent lung. Pathological anatomy]. Arch Tisiol Mal Appar Respir (1968) 0.75
[Experimental studies on the tracheobronchial reactivity in animals with exogenous pollutants]. Bronchopneumologie (1977) 0.75
[Immunodeficiency syndrome: "thymopentin"]. Arch Monaldi Mal Torace (1994) 0.75